Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Risk, correlations continue decline except for China, Japan - Axioma

Tuesday, April 30, 2013

Bailey McCann, Opalesque New York: Risk declined in the first quarter of 2013, the fifth consecutive quarter in which overall risk levels slid lower, according to Axioma Insight: Quarterly Risk Review, a report on the state of risk in publicly traded equity markets around the globe. Axioma is a global firm providing risk management solutions provider to global financial institutions including asset managers, hedge funds, pension funds and investment banks. According to the report, despite geopolitical concerns such as new elections, Cyprus, and sequestration in the US markets continued to be relatively strong and risk levels continued their steady decline.

Asset-asset correlations fell to five-plus year lows in most markets during the quarter, driving a continued decrease in top-line risk. "Once again, we detected no definitive undercurrents pointing to an imminent reversal of the current risk regime," said Melissa Brown, CFA, Senior Director, Applied Research and co-author of the Quarterly Risk Review in a statement.

"Not only were the assets within markets much more differentiated, but the markets themselves appeared to be slightly less correlated," said Brown. "From a risk perspective, the current investment landscape is substantially different from the crisis-driven markets that resulted from the global and European financial crises. With markets no longer in lockstep, equity investment managers and asse......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its